17-42160141-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_012285.3(KCNH4):āc.2953G>Cā(p.Glu985Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000385 in 1,610,448 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012285.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH4 | NM_012285.3 | c.2953G>C | p.Glu985Gln | missense_variant | 16/17 | ENST00000264661.4 | NP_036417.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH4 | ENST00000264661.4 | c.2953G>C | p.Glu985Gln | missense_variant | 16/17 | 1 | NM_012285.3 | ENSP00000264661.2 | ||
KCNH4 | ENST00000607371.5 | c.2953G>C | p.Glu985Gln | missense_variant | 16/17 | 5 | ENSP00000475564.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248282Hom.: 0 AF XY: 0.00000746 AC XY: 1AN XY: 134086
GnomAD4 exome AF: 0.0000391 AC: 57AN: 1458364Hom.: 0 Cov.: 31 AF XY: 0.0000386 AC XY: 28AN XY: 725190
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74280
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | The c.2953G>C (p.E985Q) alteration is located in exon 16 (coding exon 16) of the KCNH4 gene. This alteration results from a G to C substitution at nucleotide position 2953, causing the glutamic acid (E) at amino acid position 985 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at